Skip to main content
. 2019 May 10;20(9):2322. doi: 10.3390/ijms20092322
6MWT 6-min walk test
99mTc-DPD Tc-99m-3,3-diphosphono-1,2-propanodicarboxylicacid
AL light chain amyloidosis
APC antigen presenting cells
ASO anti-sense oligonucleotide
ATII angiotensin II
ATTR transthyretin amyloidosis
CCL2 CC-chemokine ligand 2
CCR2 C-C chemokine receptor type 2
cGMP cyclic guanosine monophosphate
CMRI cardiac magnetic resonance imaging
CRP C-reactive protein
CsA cyclosporin A
DAMPs danger-associated molecular patterns
DCs dendritic cells
EC European Commission
ECG electrocardiogram
ECM extracellular matrix
FAP familial amyloid polyneuropathy
FDA Food and Drug Administration
hATTR hereditary transthyretin amyloidosis
HF heart failure
HFpEF heart failure with preserved ejection fraction
HFrEF heart failure with reduced ejection fraction
ICAM1 intracellular adhesion molecule 1
IVIg immunoglobulins
IL-1 Interleukin-1
IL-1β Interleukin-1β
IL-10 Interleukin-10
IL-6 Interleukin-6
LVEF left ventricular ejection fraction
LVH left ventricular hypertrophy
LYVE-1 lymphatic vessel endothelial hyaluronan receptor 1
MI myocardial infarction
MMPs matrix metalloproteinases
MRI magnetic resonance imaging
MTX methotrexate
NAC N-acetylcysteine
NF-κB nuclear factor kappa-light-chain-enhancer of activated B-cells
NO nitric oxide
NT-proBNP N-terminal prohormone of brain natriuretic peptide
PCI percutaneous coronary intervention
PKG protein kinase G
ROS reactive oxygen species
SAP SLAM-associated protein
sGC soluble guanylyl cyclase
siRNA small-interfering RNA
STEMI ST-elevated myocardial infarction
TAC transverse aortic constriction
TGF-β transforming growth factor beta
TNF-α Tumor necrosis factor alpha
TNFR1 TNF receptor 1
TNFR2 TNF receptor 2
TTR transthyretin
TUDCA tauroursodeoxycholic acid
UDCA ursodeoxycholic acid
VEGF vascular endothelial growth factor
VEGF-C vascular endothelial growth factor-C
VCAM1 vascular cell adhesion protein 1
wtATTR wild-type transthyretin amyloidosis